107 related articles for article (PubMed ID: 2111194)
1. Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma: blastogenic response, interleukin-2 production and interferon-gamma production of lymphocytes.
Ikemoto S; Kishimoto T; Wada S; Nishio S; Maekawa M
Br J Urol; 1990 Apr; 65(4):333-8. PubMed ID: 2111194
[TBL] [Abstract][Full Text] [Related]
2. Defective interleukin-1 production of monocytes in patients with bladder cancer.
Ikemoto S; Kishimoto T; Iimori H; Morikawa Y; Hayahara N; Maekawa M
Br J Urol; 1990 Feb; 65(2):181-5. PubMed ID: 2317653
[TBL] [Abstract][Full Text] [Related]
3. Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma.
Bubeník J; Kieler J; Tromholt V; Hermann G; Jandlová T
Immunol Lett; 1988 Jun; 18(2):115-8. PubMed ID: 3261274
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladder.
Moltó L; Carballido J; Manzano L; Reyes E; Olivier C; Alvarez-Mon M
Br J Cancer; 1997; 75(12):1849-53. PubMed ID: 9192993
[TBL] [Abstract][Full Text] [Related]
5. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):336-41. PubMed ID: 429127
[TBL] [Abstract][Full Text] [Related]
6. Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.
Molto L; Alvarez-Mon M; Carballido J; Manzano L; Guillen C; Prieto A; Olivier C; Rodriguez-Zapata M
Br J Cancer; 1994 Dec; 70(6):1247-51. PubMed ID: 7981084
[TBL] [Abstract][Full Text] [Related]
7. Coproduction of interleukin-2 and interferon-gamma in human mononuclear cells.
Pearlstein KT; Palladino MA; Stone-Wolff DS; Oettgen HF; Vilcek J
J Biol Response Mod; 1983; 2(1):81-91. PubMed ID: 6417283
[TBL] [Abstract][Full Text] [Related]
8. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.
Ikemoto S; Wada S; Kamizuru M; Hayahara N; Kishimoto T; Maekawa M
Cancer Immunol Immunother; 1992; 34(5):289-93. PubMed ID: 1540974
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R
Br J Cancer; 1995 Apr; 71(4):801-7. PubMed ID: 7710947
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
Yuan XK; Zhao XK; Xia YC; Zhu X; Xiao P
J Int Med Res; 2011; 39(4):1381-91. PubMed ID: 21986138
[TBL] [Abstract][Full Text] [Related]
12. [Level and significance of the soluble interleukin-2 receptor expression in serum of patients with bladder cancer].
Wen R; Xie S; Ma P
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):16-8. PubMed ID: 9275680
[TBL] [Abstract][Full Text] [Related]
13. Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants.
Miyawaki T; Seki H; Taga K; Sato H; Taniguchi N
Clin Exp Immunol; 1985 Feb; 59(2):505-11. PubMed ID: 3919982
[TBL] [Abstract][Full Text] [Related]
14. Effects of natural human interferon-alpha, -beta and -gamma on interleukin 2 production in human peripheral lymphocytes.
Ohno Y; Aoki N; Maeda M
Immunol Lett; 1988 Apr; 17(4):339-44. PubMed ID: 2453458
[TBL] [Abstract][Full Text] [Related]
15. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
16. Impaired cell-mediated immunity in the first week after burn injury: investigation of spontaneous blastogenic transformation, PHA, IL-2 response and plasma suppressive activity.
Zöch G; Hamilton G; Rath T; Meissl G; Kneidl R; Roth E; Funovics J
Burns Incl Therm Inj; 1988 Feb; 14(1):7-14. PubMed ID: 3259450
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutinin-stimulated human T cells.
Kanda N; Watanabe S
J Immunol; 2001 Jan; 166(1):72-80. PubMed ID: 11123278
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma. Depression of cell-mediated immunity by adherent cells.
Ikemoto S; Kishimoto T; Nishio S; Mori K; Maekawa M
Eur Urol; 1988; 15(3-4):252-5. PubMed ID: 2975223
[TBL] [Abstract][Full Text] [Related]
19. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.
Reyes E; Carballido J; Prieto A; Molto L; Manzano L; Alvarez-Mon M
Eur Urol; 1997; 31(4):472-7. PubMed ID: 9187910
[TBL] [Abstract][Full Text] [Related]
20. Dissociated production of interleukin-2 and immune gamma-interferon by phytohaemoagglutinin stimulated peripheral mononuclear cells in type 1 (insulin-dependent) diabetes.
Giordano C; Caruso C; Panto F; Modica MA; Zambito AM; Amato MP; Galluzzo A
J Clin Lab Immunol; 1988 Oct; 27(2):73-6. PubMed ID: 3150011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
